Frameless stereotactic radiosurgery for brain metastasis: a systematic review and meta-analysis
Stereotactic Radiosurgery (SRS) delivers a high dose of radiation to a specific brain area while limiting radiation to nearby healthy tissue. While most SRS has traditionally been performed with a stereotactic frame-based approach, this study aims to investigate the safety and efficacy of frameless...
Gespeichert in:
| Veröffentlicht in: | Neurosurgical review 2024-08, Vol.47 (1), p.423, Article 423 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | 1 |
| container_start_page | 423 |
| container_title | Neurosurgical review |
| container_volume | 47 |
| creator | Habibi, Mohammad Amin Mirjnani, Mohammad Sina Ghazizadeh, Yalda Norouzi, Alireza Minaee, Poriya Eazi, SeyedMohammad Atarod, Mohammad Hosein Aliasgary, Aliakbar Noroozi, Mohammad Zaman Hajikarimloo, Bardia Sheehan, Jason P. |
| description | Stereotactic Radiosurgery (SRS) delivers a high dose of radiation to a specific brain area while limiting radiation to nearby healthy tissue. While most SRS has traditionally been performed with a stereotactic frame-based approach, this study aims to investigate the safety and efficacy of frameless radiosurgery in patients with brain metastases. Our study followed the recommended guidelines summarized in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. The electronic databases of PubMed/Medline, Scopus, Embase, and Web of Science (WOS) were searched from inception to 10 October 2023. The pooled rate of outcomes was calculated using random effect model and Restricted maximum–likelihood (REML) method. All statistical analysis was performed by STATA V.17. A total of 499 studies were recruited from the electronic databases. After removing duplicates (
n
= 117), 382 studies were used for title/abstract, and 329 were removed from the study selection process. A total of 53 articles were used for full-text assessment, and 35 studies were included for data extraction. Our analysis revealed a significant increase across all pooled survival rates and local control rates by initiating the radiosurgery for patients, estimating the pooled 6-month OSR of 75% (95% CI: 68-81%), 1-year overall survival rate (OSR) of 60% (95% CI: 51-69%), 18-month OSR of 48% (95% CI: 10-85%), 2-year OSR of 39% (95% CI: 19-58%), 1-year progression-free survival rate (PFSR) of 68% (95% CI: 39-98%), 2-year PFSR of 75% (95% CI: 58-91%), 6-month local control rate (LCR) of 93% (95% CI: 90-96%), and 12-month LCR of 86% (95% CI: 82-90%). Our meta-analysis findings confirm the efficacy of frameless radiosurgery in treating brain metastases. Using data from several trials, we were able to demonstrate stereotactic radiosurgery’s effectiveness as a therapy option for brain metastasis patients, demonstrating local control and reasonable overall survival. |
| doi_str_mv | 10.1007/s10143-024-02666-9 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3092368582</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3092368582</sourcerecordid><originalsourceid>FETCH-LOGICAL-c228t-63d07f6a314a50cf530947ec17f70f327c466addd1499a1550c873e82309bed73</originalsourceid><addsrcrecordid>eNp9kE1LAzEURYMotlb_gAvJ0s1oPmaSjjspVoWCG12H18kbmTIfNW9GmX9vbFVcCQkJybkX3mHsXIorKYS9JilkqhOh0riNMUl-wKbxxSZKK3H45z5hJ0QbIaTNhTxmE51LbeZKT5lbBmiwRiJOPQbseij6quABfNXREF4xjLzsAl8HqFreYA8UV0U3HDiNMdPAjsf3Cj84tH7HJNBCPUbslB2VUBOefZ8z9rK8e148JKun-8fF7SoplJr3idFe2NKAlilkoigzLfLUYiFtaUWplS1SY8B7L9M8B5lFZm41xhFEvkZv9Yxd7nu3oXsbkHrXVFRgXUOL3UAuciqOnMXEjKk9WoSOKGDptqFqIIxOCvcl1u3FuijW7cS6PIYuvvuHdYP-N_JjMgJ6D1D8aqM2t-mGEC3Qf7WfyBuEag</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3092368582</pqid></control><display><type>article</type><title>Frameless stereotactic radiosurgery for brain metastasis: a systematic review and meta-analysis</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Habibi, Mohammad Amin ; Mirjnani, Mohammad Sina ; Ghazizadeh, Yalda ; Norouzi, Alireza ; Minaee, Poriya ; Eazi, SeyedMohammad ; Atarod, Mohammad Hosein ; Aliasgary, Aliakbar ; Noroozi, Mohammad Zaman ; Hajikarimloo, Bardia ; Sheehan, Jason P.</creator><creatorcontrib>Habibi, Mohammad Amin ; Mirjnani, Mohammad Sina ; Ghazizadeh, Yalda ; Norouzi, Alireza ; Minaee, Poriya ; Eazi, SeyedMohammad ; Atarod, Mohammad Hosein ; Aliasgary, Aliakbar ; Noroozi, Mohammad Zaman ; Hajikarimloo, Bardia ; Sheehan, Jason P.</creatorcontrib><description>Stereotactic Radiosurgery (SRS) delivers a high dose of radiation to a specific brain area while limiting radiation to nearby healthy tissue. While most SRS has traditionally been performed with a stereotactic frame-based approach, this study aims to investigate the safety and efficacy of frameless radiosurgery in patients with brain metastases. Our study followed the recommended guidelines summarized in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. The electronic databases of PubMed/Medline, Scopus, Embase, and Web of Science (WOS) were searched from inception to 10 October 2023. The pooled rate of outcomes was calculated using random effect model and Restricted maximum–likelihood (REML) method. All statistical analysis was performed by STATA V.17. A total of 499 studies were recruited from the electronic databases. After removing duplicates (
n
= 117), 382 studies were used for title/abstract, and 329 were removed from the study selection process. A total of 53 articles were used for full-text assessment, and 35 studies were included for data extraction. Our analysis revealed a significant increase across all pooled survival rates and local control rates by initiating the radiosurgery for patients, estimating the pooled 6-month OSR of 75% (95% CI: 68-81%), 1-year overall survival rate (OSR) of 60% (95% CI: 51-69%), 18-month OSR of 48% (95% CI: 10-85%), 2-year OSR of 39% (95% CI: 19-58%), 1-year progression-free survival rate (PFSR) of 68% (95% CI: 39-98%), 2-year PFSR of 75% (95% CI: 58-91%), 6-month local control rate (LCR) of 93% (95% CI: 90-96%), and 12-month LCR of 86% (95% CI: 82-90%). Our meta-analysis findings confirm the efficacy of frameless radiosurgery in treating brain metastases. Using data from several trials, we were able to demonstrate stereotactic radiosurgery’s effectiveness as a therapy option for brain metastasis patients, demonstrating local control and reasonable overall survival.</description><identifier>ISSN: 1437-2320</identifier><identifier>EISSN: 1437-2320</identifier><identifier>DOI: 10.1007/s10143-024-02666-9</identifier><identifier>PMID: 39136823</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Brain Neoplasms - radiotherapy ; Brain Neoplasms - secondary ; Humans ; Medicine ; Medicine & Public Health ; Neurosurgery ; Radiosurgery - methods ; Review ; Treatment Outcome</subject><ispartof>Neurosurgical review, 2024-08, Vol.47 (1), p.423, Article 423</ispartof><rights>The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2024. Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.</rights><rights>2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c228t-63d07f6a314a50cf530947ec17f70f327c466addd1499a1550c873e82309bed73</cites><orcidid>0000-0001-8801-1158 ; 0009-0007-7553-1016 ; 0000-0002-3603-9877 ; 0000-0001-7600-6925 ; 0009-0002-1858-4908 ; 0000-0001-5419-4152 ; 0009-0001-4087-5245 ; 0009-0001-2892-7890</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s10143-024-02666-9$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s10143-024-02666-9$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,776,780,27901,27902,41464,42533,51294</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39136823$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Habibi, Mohammad Amin</creatorcontrib><creatorcontrib>Mirjnani, Mohammad Sina</creatorcontrib><creatorcontrib>Ghazizadeh, Yalda</creatorcontrib><creatorcontrib>Norouzi, Alireza</creatorcontrib><creatorcontrib>Minaee, Poriya</creatorcontrib><creatorcontrib>Eazi, SeyedMohammad</creatorcontrib><creatorcontrib>Atarod, Mohammad Hosein</creatorcontrib><creatorcontrib>Aliasgary, Aliakbar</creatorcontrib><creatorcontrib>Noroozi, Mohammad Zaman</creatorcontrib><creatorcontrib>Hajikarimloo, Bardia</creatorcontrib><creatorcontrib>Sheehan, Jason P.</creatorcontrib><title>Frameless stereotactic radiosurgery for brain metastasis: a systematic review and meta-analysis</title><title>Neurosurgical review</title><addtitle>Neurosurg Rev</addtitle><addtitle>Neurosurg Rev</addtitle><description>Stereotactic Radiosurgery (SRS) delivers a high dose of radiation to a specific brain area while limiting radiation to nearby healthy tissue. While most SRS has traditionally been performed with a stereotactic frame-based approach, this study aims to investigate the safety and efficacy of frameless radiosurgery in patients with brain metastases. Our study followed the recommended guidelines summarized in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. The electronic databases of PubMed/Medline, Scopus, Embase, and Web of Science (WOS) were searched from inception to 10 October 2023. The pooled rate of outcomes was calculated using random effect model and Restricted maximum–likelihood (REML) method. All statistical analysis was performed by STATA V.17. A total of 499 studies were recruited from the electronic databases. After removing duplicates (
n
= 117), 382 studies were used for title/abstract, and 329 were removed from the study selection process. A total of 53 articles were used for full-text assessment, and 35 studies were included for data extraction. Our analysis revealed a significant increase across all pooled survival rates and local control rates by initiating the radiosurgery for patients, estimating the pooled 6-month OSR of 75% (95% CI: 68-81%), 1-year overall survival rate (OSR) of 60% (95% CI: 51-69%), 18-month OSR of 48% (95% CI: 10-85%), 2-year OSR of 39% (95% CI: 19-58%), 1-year progression-free survival rate (PFSR) of 68% (95% CI: 39-98%), 2-year PFSR of 75% (95% CI: 58-91%), 6-month local control rate (LCR) of 93% (95% CI: 90-96%), and 12-month LCR of 86% (95% CI: 82-90%). Our meta-analysis findings confirm the efficacy of frameless radiosurgery in treating brain metastases. Using data from several trials, we were able to demonstrate stereotactic radiosurgery’s effectiveness as a therapy option for brain metastasis patients, demonstrating local control and reasonable overall survival.</description><subject>Brain Neoplasms - radiotherapy</subject><subject>Brain Neoplasms - secondary</subject><subject>Humans</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Neurosurgery</subject><subject>Radiosurgery - methods</subject><subject>Review</subject><subject>Treatment Outcome</subject><issn>1437-2320</issn><issn>1437-2320</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEURYMotlb_gAvJ0s1oPmaSjjspVoWCG12H18kbmTIfNW9GmX9vbFVcCQkJybkX3mHsXIorKYS9JilkqhOh0riNMUl-wKbxxSZKK3H45z5hJ0QbIaTNhTxmE51LbeZKT5lbBmiwRiJOPQbseij6quABfNXREF4xjLzsAl8HqFreYA8UV0U3HDiNMdPAjsf3Cj84tH7HJNBCPUbslB2VUBOefZ8z9rK8e148JKun-8fF7SoplJr3idFe2NKAlilkoigzLfLUYiFtaUWplS1SY8B7L9M8B5lFZm41xhFEvkZv9Yxd7nu3oXsbkHrXVFRgXUOL3UAuciqOnMXEjKk9WoSOKGDptqFqIIxOCvcl1u3FuijW7cS6PIYuvvuHdYP-N_JjMgJ6D1D8aqM2t-mGEC3Qf7WfyBuEag</recordid><startdate>20240813</startdate><enddate>20240813</enddate><creator>Habibi, Mohammad Amin</creator><creator>Mirjnani, Mohammad Sina</creator><creator>Ghazizadeh, Yalda</creator><creator>Norouzi, Alireza</creator><creator>Minaee, Poriya</creator><creator>Eazi, SeyedMohammad</creator><creator>Atarod, Mohammad Hosein</creator><creator>Aliasgary, Aliakbar</creator><creator>Noroozi, Mohammad Zaman</creator><creator>Hajikarimloo, Bardia</creator><creator>Sheehan, Jason P.</creator><general>Springer Berlin Heidelberg</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0001-8801-1158</orcidid><orcidid>https://orcid.org/0009-0007-7553-1016</orcidid><orcidid>https://orcid.org/0000-0002-3603-9877</orcidid><orcidid>https://orcid.org/0000-0001-7600-6925</orcidid><orcidid>https://orcid.org/0009-0002-1858-4908</orcidid><orcidid>https://orcid.org/0000-0001-5419-4152</orcidid><orcidid>https://orcid.org/0009-0001-4087-5245</orcidid><orcidid>https://orcid.org/0009-0001-2892-7890</orcidid></search><sort><creationdate>20240813</creationdate><title>Frameless stereotactic radiosurgery for brain metastasis: a systematic review and meta-analysis</title><author>Habibi, Mohammad Amin ; Mirjnani, Mohammad Sina ; Ghazizadeh, Yalda ; Norouzi, Alireza ; Minaee, Poriya ; Eazi, SeyedMohammad ; Atarod, Mohammad Hosein ; Aliasgary, Aliakbar ; Noroozi, Mohammad Zaman ; Hajikarimloo, Bardia ; Sheehan, Jason P.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c228t-63d07f6a314a50cf530947ec17f70f327c466addd1499a1550c873e82309bed73</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Brain Neoplasms - radiotherapy</topic><topic>Brain Neoplasms - secondary</topic><topic>Humans</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Neurosurgery</topic><topic>Radiosurgery - methods</topic><topic>Review</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Habibi, Mohammad Amin</creatorcontrib><creatorcontrib>Mirjnani, Mohammad Sina</creatorcontrib><creatorcontrib>Ghazizadeh, Yalda</creatorcontrib><creatorcontrib>Norouzi, Alireza</creatorcontrib><creatorcontrib>Minaee, Poriya</creatorcontrib><creatorcontrib>Eazi, SeyedMohammad</creatorcontrib><creatorcontrib>Atarod, Mohammad Hosein</creatorcontrib><creatorcontrib>Aliasgary, Aliakbar</creatorcontrib><creatorcontrib>Noroozi, Mohammad Zaman</creatorcontrib><creatorcontrib>Hajikarimloo, Bardia</creatorcontrib><creatorcontrib>Sheehan, Jason P.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Neurosurgical review</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Habibi, Mohammad Amin</au><au>Mirjnani, Mohammad Sina</au><au>Ghazizadeh, Yalda</au><au>Norouzi, Alireza</au><au>Minaee, Poriya</au><au>Eazi, SeyedMohammad</au><au>Atarod, Mohammad Hosein</au><au>Aliasgary, Aliakbar</au><au>Noroozi, Mohammad Zaman</au><au>Hajikarimloo, Bardia</au><au>Sheehan, Jason P.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Frameless stereotactic radiosurgery for brain metastasis: a systematic review and meta-analysis</atitle><jtitle>Neurosurgical review</jtitle><stitle>Neurosurg Rev</stitle><addtitle>Neurosurg Rev</addtitle><date>2024-08-13</date><risdate>2024</risdate><volume>47</volume><issue>1</issue><spage>423</spage><pages>423-</pages><artnum>423</artnum><issn>1437-2320</issn><eissn>1437-2320</eissn><abstract>Stereotactic Radiosurgery (SRS) delivers a high dose of radiation to a specific brain area while limiting radiation to nearby healthy tissue. While most SRS has traditionally been performed with a stereotactic frame-based approach, this study aims to investigate the safety and efficacy of frameless radiosurgery in patients with brain metastases. Our study followed the recommended guidelines summarized in the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) checklist. The electronic databases of PubMed/Medline, Scopus, Embase, and Web of Science (WOS) were searched from inception to 10 October 2023. The pooled rate of outcomes was calculated using random effect model and Restricted maximum–likelihood (REML) method. All statistical analysis was performed by STATA V.17. A total of 499 studies were recruited from the electronic databases. After removing duplicates (
n
= 117), 382 studies were used for title/abstract, and 329 were removed from the study selection process. A total of 53 articles were used for full-text assessment, and 35 studies were included for data extraction. Our analysis revealed a significant increase across all pooled survival rates and local control rates by initiating the radiosurgery for patients, estimating the pooled 6-month OSR of 75% (95% CI: 68-81%), 1-year overall survival rate (OSR) of 60% (95% CI: 51-69%), 18-month OSR of 48% (95% CI: 10-85%), 2-year OSR of 39% (95% CI: 19-58%), 1-year progression-free survival rate (PFSR) of 68% (95% CI: 39-98%), 2-year PFSR of 75% (95% CI: 58-91%), 6-month local control rate (LCR) of 93% (95% CI: 90-96%), and 12-month LCR of 86% (95% CI: 82-90%). Our meta-analysis findings confirm the efficacy of frameless radiosurgery in treating brain metastases. Using data from several trials, we were able to demonstrate stereotactic radiosurgery’s effectiveness as a therapy option for brain metastasis patients, demonstrating local control and reasonable overall survival.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>39136823</pmid><doi>10.1007/s10143-024-02666-9</doi><orcidid>https://orcid.org/0000-0001-8801-1158</orcidid><orcidid>https://orcid.org/0009-0007-7553-1016</orcidid><orcidid>https://orcid.org/0000-0002-3603-9877</orcidid><orcidid>https://orcid.org/0000-0001-7600-6925</orcidid><orcidid>https://orcid.org/0009-0002-1858-4908</orcidid><orcidid>https://orcid.org/0000-0001-5419-4152</orcidid><orcidid>https://orcid.org/0009-0001-4087-5245</orcidid><orcidid>https://orcid.org/0009-0001-2892-7890</orcidid></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1437-2320 |
| ispartof | Neurosurgical review, 2024-08, Vol.47 (1), p.423, Article 423 |
| issn | 1437-2320 1437-2320 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_3092368582 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Brain Neoplasms - radiotherapy Brain Neoplasms - secondary Humans Medicine Medicine & Public Health Neurosurgery Radiosurgery - methods Review Treatment Outcome |
| title | Frameless stereotactic radiosurgery for brain metastasis: a systematic review and meta-analysis |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T05%3A09%3A02IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Frameless%20stereotactic%20radiosurgery%20for%20brain%20metastasis:%20a%20systematic%20review%20and%20meta-analysis&rft.jtitle=Neurosurgical%20review&rft.au=Habibi,%20Mohammad%20Amin&rft.date=2024-08-13&rft.volume=47&rft.issue=1&rft.spage=423&rft.pages=423-&rft.artnum=423&rft.issn=1437-2320&rft.eissn=1437-2320&rft_id=info:doi/10.1007/s10143-024-02666-9&rft_dat=%3Cproquest_cross%3E3092368582%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3092368582&rft_id=info:pmid/39136823&rfr_iscdi=true |